What are the side effects of Nifedipine 60 mg in a postpartum woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Side Effects of Nifedipine 60mg Postpartum

The most common side effects of nifedipine 60mg in postpartum women are headaches, tachycardia, and peripheral edema, with peripheral edema being dose-related and occurring in approximately 22-29% of patients at this dose. 1, 2

Common Side Effects (Dose-Related)

Peripheral edema is the most frequent adverse effect, occurring in:

  • 22% at 60mg daily dosing
  • 29% at 90mg daily dosing
  • This is significantly higher than the 10% seen with placebo 2

Other Frequent Side Effects

Based on the most recent 2025 guidelines and FDA labeling, patients may experience:

  • Headaches - one of the three cardinal side effects specifically mentioned as a reason to switch to labetalol 1
  • Tachycardia - another key side effect that may warrant alternative therapy 1
  • Flushing - reported in clinical studies, can be moderate to severe in some cases 3, 4
  • Dizziness/lightheadedness 2, 4

Less Common Side Effects (3% or less incidence)

  • Constipation
  • Leg cramps
  • Epistaxis (nosebleeds)
  • Rhinitis
  • Urinary frequency 2

Serious but Rare Adverse Effects

Severe hypotension can occur, though rare. Close monitoring of vital signs is warranted, particularly in the immediate postpartum period 4, 5. One case report documented profound hypotension (<90/60 mmHg) requiring treatment discontinuation 4.

Clinical Context for Postpartum Use

Nifedipine is recommended as a first-line agent for postpartum hypertension regardless of breastfeeding status, with the advantage of once-daily dosing at 60mg that improves adherence 1. Recent evidence suggests nifedipine may actually be superior to labetalol in the postpartum period, with lower readmission rates for hypertension 6, 7.

Important Considerations

  • Minor side effects were reported in 48% of women taking nifedipine in one randomized trial, though these were generally well-tolerated 3
  • Side effects are not consistently dose-related except for peripheral edema 8
  • No adjustment needed for BMI or gestational factors 8
  • The extended-release formulation used postpartum has better tolerability than immediate-release forms

When to Consider Alternative Therapy

Switch to labetalol or add it to nifedipine if patients experience:

  • Intolerable headaches
  • Symptomatic tachycardia
  • Severe peripheral edema affecting quality of life 1

References

4
Research

Side-effect and vital sign profile of nifedipine as a tocolytic for preterm labour.

Hong Kong medical journal = Xianggang yi xue za zhi, 2008

8
Research

Nifedipine serum levels in pregnant women undergoing tocolysis with nifedipine.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2007

Related Questions

What is the appropriate dose of nifedipine for postpartum hypertension?
In a postpartum woman with blood pressure controlled on nifedipine who is experiencing headaches, what is the appropriate evaluation and management?
How should a postpartum patient with eclampsia and a blood pressure of 150/90 mmHg who is on nifedipine 30 mg once daily and breastfeeding be managed?
What is the preferred antihypertensive medication for postpartum preeclampsia?
Why is nifedipine preferred as the first‑line antihypertensive for a patient with asthma, a history of hypertension, and a potential pregnancy?
What is the recommended management for venous aneurysms?
What is the differential diagnosis of sterile pyuria with hematuria in a 60-year-old woman?
Is it safe to place a patient on scheduled intravenous morphine every 4 hours together with a fentanyl transdermal patch?
What is the recommended starting dose and titration schedule for Strattera (atomoxetine) in an adult patient?
How should I transition a patient from Strattera (atomoxetine) 40 mg daily to Effexor (venlafaxine)?
In a 76-year-old patient with hemoglobin A1c 10.6%, glomerular filtration rate 75 mL/min/1.73 m², coronary artery disease, and currently on metformin, empagliflozin (Jardiance), and gliclazide modified‑release, what is the optimal diabetes management plan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.